Archives de l’auteur : oxeltis
Oxeltis is present at BIO International Convention in Boston (MA), USA ! We look forward to seeing you there. For any appointments you can check our profile on One on One Partnering or send us an email : firstname.lastname@example.org.
Oxeltis is at Meet2Win, Oncology business convention in Bordeaux, May 17-18. Come to discuss your current and future projects involving medicinal chemistry (FTE contracts for Hit selection & optimization, H2L work, Lead optimization…) and small molecule custom synthesis. See you … Continuer la lecture
Oxeltis will be present at OncoWeek Toulouse, looking forward meeting you email@example.com
Oxeltis is pleased to announce to its customers and R&D partners the renewal of its agreement for R&D tax credit (agrément Crédit Impôt Recherche) by the French Ministry of Higher Education and Research for years 2017, 2018 and 2019. … Continuer la lecture
Position: Post Doc (PhD) in Organic Synthesis / Medicinal Chemistry in Montpellier (France) – fix term contract 12 months, starting Feb-March 2017 The Post Doc in medicinal chemistry will be responsible for the proposal, synthesis, characterization and study of heterocyclic and … Continuer la lecture
Oxeltis team will attend Biofit 2016 in Lille – France (29th Nov. – 1st Dec. 2016), and will be happy to meet you to discuss your current and future projects involving medicinal chemistry and custom synthesis. We look forward meeting … Continuer la lecture
Oxeltis will be happy to meet you at the International Round Table in Paris, July 18-22, 2016 to discuss your current and future projects involving nucleoside chemistry. Oxeltis is known for – Several references in antiviral and oncology medicinal chemistry … Continuer la lecture